Elevated Plasma IL-37, IL-18, and IL-18BP Concentrations in Patients with Acute Coronary Syndrome

Figure 1

The plasma IL-37, IL-18, and IL-18BP levels in each group. (a) The plasma IL-37 levels in patients with AMI and UAP were significantly increased compared with those of the control and SAP groups. (b) The plasma IL-18 levels in patients with AMI and UAP were significantly increased compared with those of the control and SAP groups, and the plasma IL-18 levels in patients with SAP were significantly increased compared with those of the control group. (c) The plasma IL-18BP levels in patients with AMI and UAP were significantly increased compared with those of the control and SAP groups, and the plasma IL-18BP levels in patients with SAP were significantly increased compared with those of the control group. (d) The levels of IL-37 were positively correlated with the levels of IL-18 (𝑟=0.56, 𝑃<0.01). (e) The levels of IL-37 were positively correlated with the levels of IL-18BP (𝑟=0.55, 𝑃<0.01). (f) The levels of IL-18 were positively correlated with the levels of IL-18BP (𝑟=0.72, 𝑃<0.01). ^∗𝑃<0.05 versus Control, ^∗∗𝑃<0.01 versus Control, ^##𝑃<0.01 versus SAP.

(a)

(b)

(c)

(d)

(e)

(f)